 |
allogeneic mesenchymal precursor cells derived from ex vivo healthy donors harvested from iliac crest. |
|---|---|
| Trade Name | |
| Orphan Indication | Insufficient hematopoietic stem cell production in patients with hematologic malignancies who have failed treatment with conventional chemotherapy |
| USA Market Approval | USA |
| USA Designation Date | 2008-09-12 00:00:00 |
| Sponsor | Mesoblast, Inc.;275 Madison Avenue, 4th Floor;New York, NY, 10016 |
